
Company valuation, historical trends, and peer comparisons.
According to Scancell Holdings plc’s latest financial reports and current stock price. The company's current Enterprise Value is 114.80M. This represents a change of -8.44% compared to the average of 125.39M of the last 4 quarters.
The mean historical Enterprise Value of Scancell Holdings plc over the last ten years is 79.46M. The current 114.80M Enterprise Value has changed 44.47% with respect to the historical average. Over the past ten years (40 quarters), SCNLF's Enterprise Value was at its highest in in the April 2026 quarter at 157.25M. The Enterprise Value was at its lowest in in the April 2007 quarter at -1504938.00.
Average
79.46M
Median
87.96M
Minimum
15.76M
Maximum
157.02M
Discovering the peaks and valleys of Scancell Holdings plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 277.07%
Maximum Annual Enterprise Value = 157.02M
Minimum Annual Increase = -43.37%
Minimum Annual Enterprise Value = 15.76M
| Year | Enterprise Value | Change |
|---|---|---|
| 2026 | 157.02M | 51.45% |
| 2025 | 103.68M | 26.47% |
| 2024 | 81.98M | -36.31% |
| 2023 | 128.72M | 37.03% |
| 2022 | 93.94M | -23.98% |
| 2021 | 123.57M | 277.07% |
| 2020 | 32.77M | 107.87% |
| 2019 | 15.76M | -43.37% |
| 2018 | 27.84M | -5.15% |
| 2017 | 29.35M | -2.64% |
The current Enterprise Value of Scancell Holdings plc (SCNLF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
114.23M
5-year avg
113.07M
10-year avg
79.46M
Scancell Holdings plc’s Enterprise Value is greater than Botanix Pharmaceuticals Limited (-969039.00), less than Innate Pharma S.A. (131.50M), greater than NDT Pharmaceuticals Inc. (8.51M), greater than Molecular Partners AG (44.92M), less than Brii Biosciences Limited (130.49M), less than Hofseth BioCare ASA (682.72M), less than Kintor Pharmaceutical Limited (654.66M), greater than Poolbeg Pharma PLC (44.04M), less than NervGen Pharma Corp. (115.59M), greater than Orexo AB (publ) (-95136895.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -969039.00 | $20.17M | |
| 131.50M | $141.70M | |
| 8.51M | $7.89M | |
| 44.92M | $153.72M | |
| 130.49M | $93.77M | |
| 682.72M | $48.62M | |
| 654.66M | $76.61M | |
| 44.04M | $73.14M | |
| 115.59M | $312.89M | |
| -95136895.00 | $15.56M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Scancell Holdings plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Scancell Holdings plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Scancell Holdings plc's Enterprise Value?
What is the highest Enterprise Value for Scancell Holdings plc (SCNLF)?
What is the 3-year average Enterprise Value for Scancell Holdings plc (SCNLF)?
What is the 5-year average Enterprise Value for Scancell Holdings plc (SCNLF)?
How does the current Enterprise Value for Scancell Holdings plc (SCNLF) compare to its historical average?